Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.70
1.56 (3.11%)
At close: Aug 15, 2025, 12:13 PM

Anbio Biotechnology Class A Ordinary Shares Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023
Revenue
8.85M 10.27M 7.26M 3.31M
Cost of Revenue
2.49M 4.35M 3.62M 1.36M
Gross Profit
6.36M 5.92M 3.63M 1.94M
Operating Income
2.15M 4.47M 2.12M 1.54M
Interest Income
365.13K 309.72K 178.81K 18.75K
Pretax Income
2.56M 4.68M 2.44M 1.64M
Net Income
2.56M 4.68M 2.44M 1.64M
Selling & General & Admin
3.72M 1.16M 1.37M 406.06K
Research & Development
491.49K 283.72K 145.7K n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
4.21M 1.45M 1.51M 406.06K
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-6.7M -5.8M -5.14M -1.77M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
42.29M 42.29M 42.29M 42.29M
Shares Outstanding (Diluted)
42.29M 42.29M 42.29M 42.29M
EPS (Basic)
0.06 0.11 0.06 0.04
EPS (Diluted)
0.06 0.11 0.06 0.04
EBITDA
2.56M 4.68M 2.45M 1.65M
EBIT
2.56M 4.68M 2.44M 1.64M
Depreciation & Amortization
n/a 3.54K 13.03K 9.49K